dc.contributor.author | Al-Lazikani, B | |
dc.contributor.author | Workman, P | |
dc.date.accessioned | 2016-11-28T13:30:53Z | |
dc.date.issued | 2016-09-01 | |
dc.identifier.citation | Future medicinal chemistry, 2016, 8 (14), pp. 1711 - 1716 | |
dc.identifier.issn | 1756-8919 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/313 | |
dc.identifier.eissn | 1756-8927 | |
dc.identifier.doi | 10.4155/fmc-2016-0133 | |
dc.format | Print-Electronic | |
dc.format.extent | 1711 - 1716 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | FUTURE SCI LTD | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Neoplasms | |
dc.subject | Proteins | |
dc.subject | Proteomics | |
dc.subject | Protein Conformation | |
dc.subject | Databases, Factual | |
dc.subject | Drug Discovery | |
dc.subject | Data Mining | |
dc.subject | Protein Interaction Maps | |
dc.subject | Machine Learning | |
dc.title | Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactome. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2016-07-28 | |
rioxxterms.versionofrecord | 10.4155/fmc-2016-0133 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2016-09 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Future medicinal chemistry | |
pubs.issue | 14 | |
pubs.notes | No embargo | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics | |
pubs.publication-status | Published | |
pubs.volume | 8 | |
pubs.embargo.terms | No embargo | |
icr.researchteam | Computational Biology and Chemogenomics | |
dc.contributor.icrauthor | Al-Lazikani, Bissan | |
dc.contributor.icrauthor | Workman, Paul | |